Abstract:Objective The investigation aimed at producing transgenic mouse model with myocardium-specific overex-pression of human KCNE4 (hKCNE4) gene so as to research into the prophylactic and therapeutic effect of hKCNE4 gene on a certain subset of atrial fibrillation. Methods hKCNE 4 gene was cloned by reverse transcription-polymerase chain reaction (RT-PCR), digested with restrictive endonuclease, and inserted into the cardiomyocyte-specific expressing plasmidα-MHC-Clone 26 by ligase. Enzymatic and sequencing analyses were performed to confirm hKCNE4-α-MHC-Clone 26 prior to obtaining the BamHI treated transgenic element hKCNE4-α-MHC-hGH pA. The hKCNE4-α-MHC-hGH pA was microinjected into the male pronucleus of fertilized oocyte of C57BL mice and the oocytes surviving microin-jection were transplanted into the oviducts of pseudo-pregnant mice. The positive transgenic founder (G0 generation) mice were identified by PCR from offspring generated by pseudo-pregnant mice. The G0 transgenic mice were mated respectively with wild-type C57BL mice to reproduce G1 transgenic progeny. RT-PCR and sequencing were applied to screening for transgenic mice expressing hKCNE4 from G1 transgenic descendants. Results hKCNE4 gene was cloned and ligated to the vectorα-MHC-Clone 26 correctly. 86 mice were generated 9 of which were identified to be transgenic and the trans-gene hKCNE 4 carried by 2 transgenic mice (titled as Line A and Line B respectively) was not only transmitted to the next generation but also overexpressed restrictedly in the hearts. Preliminary phenotypic analysis on the transgenic progeny of Line A and Line B showed that they developed normally, reproduced generally, and suffered from no arrhythmia documented by surface electrocardiography. Conclusion The results indicate that the transgenic mice cardiomyocyte-specifically overexpressing hKCNE 4 are successfully procured, which provides a valuable tool for the exploration of the preventive and remedial influence of hKCNE 4 on a subgroup of atrial fibrillation.

Establishment and Identification of H2-K/β_2-m Double Transgenic Mouse

Mouse Heterotopic Abdominal Heart Transplant Model

The Cloning and Sequencing of H-2Kk Gene Cdna of 615 Mice

Construction and expression of HLA-DR(α), DRB1 * 0401 transgenic mice model

Construction and Identification of the Mouse Β2m Sense and Antisense RNA

Establishment of Hamster- and Human-Prnp Transgenic Mice.

Establishment of a Dlx2 conditional activation transgenic mouse model

Establishment of Double-gene Transgenic Mouse Model for Hht and Hdaf Through SMGT

Establishment of transgenic mouse models expressing human HSP22 protein

Establishment and identification of transgenic breast cancer mouse model with Her2 overexpression

Animal Model for Heterologous Transplantation-Generating of Transgenic Mice That Expresses Hcd59 Cdna

Establishment of DMD Immunodeficient Mouse Model and Its Gene Identification

[Construction of MHC I Gene Retroviral Expression Vector and Its Expression in Hematopoietic Cells].

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene

Establishment of Transgenic Mice Carrying the Gene of Human Nuclear Receptor NR5A2 (Hb1f)

Establishment of Mouse Model Highly Expressing Bcl-2 Protein

Establishment of Widely Expressed Hb1f Transgenic Mouse Lineage and Its Morphologic Analysis

Generation of Transgenic Mice with Liver-Specific Expression of Human Nuclear Receptor Nr5a2.

Establishment of a heteroplasmic mouse strain with interspecific mitochondrial DNA haplotypes and improvement of a PCR-RFLP-based measurement system for estimation of mitochondrial DNA heteroplasmy

Generation of transgenic mice with liver-specific expression of delta drosophila homolog-like 1

Establishment of Human Interferon-Alpha Transgen- Ic Mice Model